Dermatology 2023 | International Conference on Dermatology and cosmetology

Researchers identified patient- and tumor-level melanoma features in black individuals. source https://www.news-medical.net/news/20240125/Study-addresses-knowledge-gap-of-clinical-features-and-outcomes-of-Black-patients-with-melanoma.aspx

A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis. source https://www.news-medical.net/news/20240123/Scientists-identify-a-new-approach-to-treating-sarcoidosis.aspx

Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer. source https://www.news-medical.net/news/20240119/Immune-checkpoint-inhibitor-target-found-to-promote-skin-cancer-growth.aspx

Children with the condition aplasia cutis congenita (ACC) are born with the absence of skin along the midline of the scalp. source https://www.news-medical.net/news/20240103/Missing-proteins-explain-century-old-mystery-of-scalp-skin-absence-in-children.aspx

Researchers at the Icahn School of Medicine at Mount Sinai have gained a deeper understanding of the nuanced roles of JAK inhibitors, or modulators, in inflammation across various cell types and tissues. source https://www.news-medical.net/news/20231221/Unraveling-nuanced-roles-of-JAK-inhibitors-in-inflammation.aspx

New research indicates that higher doses of topical corticosteroids, which are commonly used to treat inflammatory skin conditions, are linked with elevated risks of osteoporosis and bone fractures associated with osteoporosis. source https://www.news-medical.net/news/20231220/Higher-doses-of-topical-corticosteroids-linked-to-increased-risks-of-osteoporosis-and-bone-fractures.aspx